Review



myc tag 9b11 cst  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Cell Signaling Technology Inc myc tag 9b11 cst
    Myc Tag 9b11 Cst, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 2829 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/myc tag 9b11 cst/product/Cell Signaling Technology Inc
    Average 99 stars, based on 2829 article reviews
    myc tag 9b11 cst - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    99
    Cell Signaling Technology Inc myc tag 9b11 cst
    Myc Tag 9b11 Cst, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/myc tag 9b11 cst/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    myc tag 9b11 cst - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc antibody cst 9b11
    Antibody Cst 9b11, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody cst 9b11/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    antibody cst 9b11 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc myc (cst 9b11) antibody
    Myc (Cst 9b11) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/myc (cst 9b11) antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    myc (cst 9b11) antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc 9b11 cst
    9b11 Cst, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/9b11 cst/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    9b11 cst - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc 9b11 cst 2276s
    9b11 Cst 2276s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/9b11 cst 2276s/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    9b11 cst 2276s - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc anti-myc antibody cst #9b11
    ( a ) Schematic of the locations of anti-KCC2 antibodies. ( b ) The primary KCC2 amino acid sequence. Red indicates the protein coverage of KCC2 identified by MS analysis; yellow indicates unique coverage for KCC2a and <t>KCC2b</t> isoforms. MS/MS- spectra of peptides unique for KCC2a and KCC2b. Right: the MS/MS ion fragmentation of the corresponding amino acid sequence is indicated above the spectra. ( c ) Spectral and peptide count plots of proteins in AP with all three anti-KCC2 antibodies in developing brain membrane fractions (P5, left) and adult brain membrane fractions (P50, right). Peptide and spectral counts are normalized (anti-KCC2/IgG) and plotted on a log scale. Red circles - highly enriched KCC2 bait. Blue circles - highly enriched PACSIN1 target peptides. Dark-grey circles - top proteins enriched with KCC2-AP in comparison to IgG control-AP. Light-grey circles - proteins enriched in IgG control-AP in comparison to KCC2-AP and known spurious interactors. 10.7554/eLife.28270.009 Figure 2—source data 1. LC/MS replicates.
    Anti Myc Antibody Cst #9b11, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-myc antibody cst #9b11/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-myc antibody cst #9b11 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( a ) Schematic of the locations of anti-KCC2 antibodies. ( b ) The primary KCC2 amino acid sequence. Red indicates the protein coverage of KCC2 identified by MS analysis; yellow indicates unique coverage for KCC2a and KCC2b isoforms. MS/MS- spectra of peptides unique for KCC2a and KCC2b. Right: the MS/MS ion fragmentation of the corresponding amino acid sequence is indicated above the spectra. ( c ) Spectral and peptide count plots of proteins in AP with all three anti-KCC2 antibodies in developing brain membrane fractions (P5, left) and adult brain membrane fractions (P50, right). Peptide and spectral counts are normalized (anti-KCC2/IgG) and plotted on a log scale. Red circles - highly enriched KCC2 bait. Blue circles - highly enriched PACSIN1 target peptides. Dark-grey circles - top proteins enriched with KCC2-AP in comparison to IgG control-AP. Light-grey circles - proteins enriched in IgG control-AP in comparison to KCC2-AP and known spurious interactors. 10.7554/eLife.28270.009 Figure 2—source data 1. LC/MS replicates.

    Journal: eLife

    Article Title: Native KCC2 interactome reveals PACSIN1 as a critical regulator of synaptic inhibition

    doi: 10.7554/eLife.28270

    Figure Lengend Snippet: ( a ) Schematic of the locations of anti-KCC2 antibodies. ( b ) The primary KCC2 amino acid sequence. Red indicates the protein coverage of KCC2 identified by MS analysis; yellow indicates unique coverage for KCC2a and KCC2b isoforms. MS/MS- spectra of peptides unique for KCC2a and KCC2b. Right: the MS/MS ion fragmentation of the corresponding amino acid sequence is indicated above the spectra. ( c ) Spectral and peptide count plots of proteins in AP with all three anti-KCC2 antibodies in developing brain membrane fractions (P5, left) and adult brain membrane fractions (P50, right). Peptide and spectral counts are normalized (anti-KCC2/IgG) and plotted on a log scale. Red circles - highly enriched KCC2 bait. Blue circles - highly enriched PACSIN1 target peptides. Dark-grey circles - top proteins enriched with KCC2-AP in comparison to IgG control-AP. Light-grey circles - proteins enriched in IgG control-AP in comparison to KCC2-AP and known spurious interactors. 10.7554/eLife.28270.009 Figure 2—source data 1. LC/MS replicates.

    Article Snippet: Cell lysates or solubilized membrane fractions (∼0.2–0.5 mg protein) were incubated with N-terminal KCC2b or anti-myc (CST #9B11, RRID AB_331783 ) antibodies on a rotating platform (4 hr, 4°C).

    Techniques: Sequencing, Tandem Mass Spectroscopy, Membrane, Comparison, Control, Liquid Chromatography with Mass Spectroscopy

    Native KCC2 complexes from C 12 E 9 -solubilized whole-brain membrane fractions immunoprecipitated with pre-immune sera or anti-N-terminal KCC2b antibody ( a ) or anti-p Ser 940 KCC2 antibody ( b ) and immunoblotted with the antibodies indicated at right (C-terminal KCC2 antibody). Representative example of five biological replicates. IP, immunoprecipitate; I, input fraction (1% of IP); U. unbound fraction (1%of IP); O. oligomer; M. monomer.

    Journal: eLife

    Article Title: Native KCC2 interactome reveals PACSIN1 as a critical regulator of synaptic inhibition

    doi: 10.7554/eLife.28270

    Figure Lengend Snippet: Native KCC2 complexes from C 12 E 9 -solubilized whole-brain membrane fractions immunoprecipitated with pre-immune sera or anti-N-terminal KCC2b antibody ( a ) or anti-p Ser 940 KCC2 antibody ( b ) and immunoblotted with the antibodies indicated at right (C-terminal KCC2 antibody). Representative example of five biological replicates. IP, immunoprecipitate; I, input fraction (1% of IP); U. unbound fraction (1%of IP); O. oligomer; M. monomer.

    Article Snippet: Cell lysates or solubilized membrane fractions (∼0.2–0.5 mg protein) were incubated with N-terminal KCC2b or anti-myc (CST #9B11, RRID AB_331783 ) antibodies on a rotating platform (4 hr, 4°C).

    Techniques: Membrane, Immunoprecipitation

    KCC2 protein partners identified by ME-APs

    Journal: eLife

    Article Title: Native KCC2 interactome reveals PACSIN1 as a critical regulator of synaptic inhibition

    doi: 10.7554/eLife.28270

    Figure Lengend Snippet: KCC2 protein partners identified by ME-APs

    Article Snippet: Cell lysates or solubilized membrane fractions (∼0.2–0.5 mg protein) were incubated with N-terminal KCC2b or anti-myc (CST #9B11, RRID AB_331783 ) antibodies on a rotating platform (4 hr, 4°C).

    Techniques:

    ( a ) Spatiotemporal expression patterns of SLC12A5 and members of receptor trafficking node of the KCC2 interactome in the human brain; RNAseq data were analyzed in hippocampus. Pcw, postconceptual weeks. ( b ) Native KCC2 complexes from C 12 E 9 -solubilized whole-brain membrane fractions immunoprecipitated with IgY or anti-N-term KCC2 (left) and IgG or anti-PACSIN1 (right), and immunoblotted with antibodies as indicated. ( c ) Western blot analysis of developmental expression patterns of KCC2 and PACSIN1. ( d ) Antibody-shift assay followed by 2D-BN-PAGE separation using whole-brain membrane fractions, incubated with antibodies indicated on left; gel separations were immunoblotted with anti-KCC2 or PACSIN1 antibodies. ( e ) Coimmunoprecipitation performed in COS7 cells transfected with myc-tagged KCC2b and GFP-tagged PACSIN1/2/3 constructs, immunoprecipitated with anti-N-term KCC2b, and immunoblotted with the antibodies indicated at right. ( f ) Immunoblot of immunoprecipitates from transfected COS7 cell lysates. * indicate the lanes where PACSIN1 lacks the variable region between ~aa325-383. # of independent biological replicates are indicated in parenthesis: (4), (3), (2). 10.7554/eLife.28270.025 Figure 5—source data 1. Human brain RNAseq data from the Allan Brain Atlas for receptor trafficking node.

    Journal: eLife

    Article Title: Native KCC2 interactome reveals PACSIN1 as a critical regulator of synaptic inhibition

    doi: 10.7554/eLife.28270

    Figure Lengend Snippet: ( a ) Spatiotemporal expression patterns of SLC12A5 and members of receptor trafficking node of the KCC2 interactome in the human brain; RNAseq data were analyzed in hippocampus. Pcw, postconceptual weeks. ( b ) Native KCC2 complexes from C 12 E 9 -solubilized whole-brain membrane fractions immunoprecipitated with IgY or anti-N-term KCC2 (left) and IgG or anti-PACSIN1 (right), and immunoblotted with antibodies as indicated. ( c ) Western blot analysis of developmental expression patterns of KCC2 and PACSIN1. ( d ) Antibody-shift assay followed by 2D-BN-PAGE separation using whole-brain membrane fractions, incubated with antibodies indicated on left; gel separations were immunoblotted with anti-KCC2 or PACSIN1 antibodies. ( e ) Coimmunoprecipitation performed in COS7 cells transfected with myc-tagged KCC2b and GFP-tagged PACSIN1/2/3 constructs, immunoprecipitated with anti-N-term KCC2b, and immunoblotted with the antibodies indicated at right. ( f ) Immunoblot of immunoprecipitates from transfected COS7 cell lysates. * indicate the lanes where PACSIN1 lacks the variable region between ~aa325-383. # of independent biological replicates are indicated in parenthesis: (4), (3), (2). 10.7554/eLife.28270.025 Figure 5—source data 1. Human brain RNAseq data from the Allan Brain Atlas for receptor trafficking node.

    Article Snippet: Cell lysates or solubilized membrane fractions (∼0.2–0.5 mg protein) were incubated with N-terminal KCC2b or anti-myc (CST #9B11, RRID AB_331783 ) antibodies on a rotating platform (4 hr, 4°C).

    Techniques: Expressing, Membrane, Immunoprecipitation, Western Blot, Shift Assay, Incubation, Transfection, Construct